Moxonidine-based combination antihypertensive therapy in patients with metabolic syndrome
Aim. To assess the effects of moxonidine-based combination therapy on clinical status, laboratory parameters, and target organs in patients with metabolic syndrome (MS). Material and methods. In total, 60 MS patients with Stage 1-2 arterial hypertension (AH) were randomised into 3 groups. Group I wa...
Saved in:
Main Authors: | E. V. Tishina, V. B. Mychka, M. A. Saidova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2012-06-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1812 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
by: E. V. Tishina, et al.
Published: (2011-06-01) -
Moxonidine for arterial hypertension treatment in menopausal women with metabolic syndrome
by: V. V. Trusov, et al.
Published: (2007-08-01) -
ADDITIONAL BENEFITS OF ANTIHYPERTENSIVE MOXONIDINE THERAPY IN POSTMENOPAUSAL WOMEN WITH ARTERIAL HYPERTENSION
by: E. N. Dudinskaya, et al.
Published: (2014-02-01) -
COMBINED ANTIHYPERTENSIVE THERAPY IN METABOLIC SYNDROME
by: E. I. Mananko, et al.
Published: (2016-01-01) -
COMBINATION OF ACE INHIBITOR WITH AGONIST OF I1 -IMIDAZOLINE RECEPTORS: NEW OPPORTUNITIES FOR ANTIHYPERTENSIVE THERAPY
by: S. V. Nedogoda
Published: (2016-12-01)